论文部分内容阅读
目的:分析二甲双胍治疗老年社区糖尿病的效果。方法:选取2014年10月至2016年1月我院的78例老年社区糖尿病患者作为观察对象,对78例老年社区糖尿病患者实施信封随机分组(对照组和实验组)。对照组39例老年社区糖尿病患者采取瑞格列奈治疗,实验组39例老年社区糖尿病患者采取二甲双胍,分析比较两组老年社区糖尿病患者的血糖情况及不良反应发生率。结果:对照组患者的不良反应发生率(20.51%)显著高于实验组患者(7.69%);实验组和对照组老年社区糖尿病患者的血糖水平存在明显差异(P<0.05)。结论:对老年社区糖尿病患者采取二甲双胍治疗,能显著降低患者的血糖水平,利于控制患者病情,且毒副作用较小。
OBJECTIVE: To analyze the effect of metformin in the treatment of elderly patients with diabetes mellitus. Methods: Seventy-eight elderly patients with diabetes mellitus in our hospital from October 2014 to January 2016 were randomly divided into two groups: control group and experimental group. In the control group, 39 elderly patients with diabetes mellitus were treated with repaglinide. 39 elderly diabetic patients in the experimental group were treated with metformin. The incidence of adverse reactions and the incidence of adverse reactions were compared between the two groups. Results: The incidence of adverse reactions in the control group (20.51%) was significantly higher than that in the experimental group (7.69%). There was a significant difference (P <0.05) in the blood glucose level between the experimental group and the control group. Conclusion: Metformin treatment of elderly patients with diabetes mellitus can significantly reduce the patient’s blood glucose levels, which will help to control the patient’s condition with less side effects.